Hemophilia and nonprogressing human immunodeficiency virus type I infection

Blood

Volumn 89, Issue 1, 1997, Pages 191-200

  Vicenzi, Elisa ^a   Bagnarelli, Patrizia ^b   Santagostino, Elena ^b   Ghezzi, Silvia ^b   Alfano, Massimo ^b   Sinnone, Marina S ^b   Fabio, Giovanna ^b   Turchetto, Lucia ^b   Moretti, Gianluca ^b   Lazzarin, Adriano ^b   Mantovani, Alberto ^b   Mannucci, Pier Mannuccio ^b   Clementi, Massimo ^b   Gringeri, Alessandro ^b   Poli, Guido ^b  

^a P2 P3 Laboratories   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 8; RANTES;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEMOPHILIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS ISOLATION; VIRUS REPLICATION;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; CHEMOKINES; COHORT STUDIES; DISEASE PROGRESSION; DNA, VIRAL; HEMOPHILIA A; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PHENOTYPE; PLASMA; PROVIRUSES; RETROSPECTIVE STUDIES; RNA, VIRAL; SURVIVORS; T-LYMPHOCYTES, REGULATORY; TIME FACTORS; VIREMIA; VIRUS CULTIVATION; VIRUS REPLICATION;

EID: 0031019493     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Fauci AS: Multifactorial nature of human immunodeficiency virus disease: Implications for therapy. Science 262:1011, 1993
2. Clark SJ, Saag MS, Don Decker W, Cambell-Hill S, Roberson JL, Veldkamp PJ, Kappes JC, Hahn BH, Shaw GM: High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N Engl J Med 324:961, 1991
3. Piatak M, Saag MS, Yang LC, Clark SJ, Kappes JC, Luk KC, Hanh BH, Shaw GM, Lifson JD: High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259:1749, 1993
4. Daar ES, Moudgil T, Meyer RD, Ho DD: Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med 324:954, 1991
5. Graziosi C, Pantaleo G, Butini L, Demarest JF, Saag MMS, Shaw GM, Fauci AS: Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection. Proc Natl Acad Sci USA 90:6405, 1993
6. Clementi M, Bagnarelli P, Menzo S, Valenza A, Manzin A, Varaldo PE: Clearance of HIV-1 viremia after seroconversion. Lancet 341:315, 1993
7. Phillips AN: Reduction of HIV concentration during acute infection: Independence from a specific immune response. Science 271:497, 1996
8. Buchbinder SP, Katz MH, Hessol NA, O'Malley PM, Holmberg SD: Long-term HIV-1 infection without immunologic progression. AIDS 8:1123, 1994
9. Easterbrook PJ: Non-progression in HIV infection. AIDS 8:1179, 1994
10. Cao Y, Qin L, Zhang L, Safrit J, Ho DD: Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus 1 infection. N Engl J Med 332:201, 1995
11. Pantaleo G, Menzo S, Vaccarezza M, Graziosi C, Cohen OJ, Demarest JF, Montefiori D, Orenstein JM, Fox C, Schrager LK, Margolick JB, Buchbinder S, Giorgi JV, Fauci AS: Studies in subjects with long-term non-progressive human immunodeficiency virus infection. N Engl J Med 332:209, 1995
12. Klein MR, van Baalen CA, Holwerda AM, Kerkhof Garde SR, Bende RJ, Keet IPM, Eeftinck-Schattenkerk JKM, Osterhaus ADME, Schuitemaker H, Miedema F: Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: A longitudinal analysis of rapid progressors and long term asymptomatics. J Exp Med 181:1365, 1995
13. Itescu S, Rose S, Dwyer E, Winchester R: Certain HLA-DR5 and DR6 major histocompatibility complex class II alleles are associated with a CD8 lymphocytic host response to human immunodeficiency virus type I characterized by low lymphocyte viral strain heterogeneity and slow disease progression. Proc Natl Acad Sci USA 91:11472, 1994
14. Kaslow RA, Carrington M, Apple R, Park L, Munoz A, Saah AJ, Goedert JJ, Wimkler C, O'Brien SJ, Rinaldo C, Detels R, Blattner W, Phair J, Erlich H, Mann DL: Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med 2:405, 1996
15. Kirchhoff F, Greenough TC, Brettler DB, Sullivan JL, Desrosiers RC: Brief report: Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med 332:228, 1995
16. Deacon NJ, Tsykin A, Solomon A, Smith K, Ludford-Menting M, Hooker DJ, McPhee DA, Greenway AL, Ellett A, Chatfield C, Lawson VA, Crowe S, Maerz A, Sonza S, Learmont J, Sullivan JS, Cunningham A, Dwyer D, Dowton D, Mills J: Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270:988, 1995
17. Kestler HW III, Ringler DJ, Mori K, Panicali DL, Sehgal PK, Daniel MD, Desrosier R: Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65:651, 1991
18. Verani P, Mariant G, Mannucci PM, De Rossi G, Nicoletti L, Titti F, Falcione E, Pasqualetti D, Ammassari M, Gringeri A, Mandelli F, Rossi GB: Prevalence of HTLV-III/LAV antibodies in Italian asymptomatic hemophiliacs given commercial concentrates of factors VIII and IX. J Med Virol 19:143, 1986
19. Gringeri A, Mannucci PM, Medical-Scientific Committee of the Fondazione dell'Emofilia: National Survey of HIV Infection in Italian Hemophiliacs: 1983-1987. Ric Clin Lab 18:75, 1988
20. + T cells. Science 270:1811, 1995
21. Paxton WA, Martin SR, Tse D, O'Brien TR, Skurnick J, VanDevanter NL, Padian N, Braun JF, Kotler DP, Wolinsky SM, Koup RA: Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple highrisk sexual exposures. Nat Med 2:412, 1996
22. Feng Y, Broder CC, Kennedy PE, Berger EA: HIV-1 entry cofactor: Cloning of a seven-transmembrane G protein-coupled receptor. Science 272:872, 1996
23. Deng H, Liu R, Eilmeler W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Pelper SC, Schall TJ, Littman DR, Landau NR: Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661, 1996
24. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667, 1996
25. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, Mackay CR, LaRosa G, Newman W, Gerard N, Gerard C, Sodroski J: The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV isolates. Cell 85:1135, 1996
26. Doranz BJ, Rucker J, Yi Y, Smyth RJ, Samson M, Peiper SC, Parmentier M, Collman RC, Dooms RW: A dual-tropic primary HIV-1 isolate that uses fusin and the b-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85:1149, 1996
27. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA: CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272:1955, 1996
28. Ghezzi S, Alfano M, Delfanti F, Biswas P, Lazzarin A, Mantovani A, Poli G, Vicenzi E: Chemokines and HIV: More than just suppression. J AIDS (in press)
29. Santagostino E, Gringeri A, Cultraro D, Tradati F, Siracusano L, Marinoni A, Mannucci PM: Factors associated with progression to AIDS and mortality in a cohort of HIV-infected patients with hemophilia followed up since seroconversion. Cell Mol Biol 41:371, 1995
30. Centers for Disease Control and Prevention. Morb Mortal Weekly Rep 41:1, 1992
31. Vicenzi E, Dimitrov DS, Engleman A, Migone TS, Purcell DFJ, Leonard J, Englund G, Martin MA: An integration defective U5 deletion mutant of HIV-1 reverts by eliminating additional LTR sequences. J Virol 68:7879, 1994
32. Koot M, Vos AHV, Keet RPM, De Goede REY, Dercksen W, Terpstra FG, Coutinho RA, Miedema F, Tersmette M: HIV-1 biological phenotype in long term infected individuals, evaluated with an MT-2 cocultivation assay. AIDS 6:49, 1992
33. Bagnarelli P, Menzo S, Manzin A, Varaldo PE, Montroni M, Giacca M, Clementi M: Detection of human immunodeficiency virus type-1 transcripts in peripheral blood lymphocytes by the polymerase chain reaction. J Virol Methods 32:31, 1991
34. Menzo S, Bagnarelli P, Giacca M, Manzin A, Varaldo PE, Clementi M: Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction. J Clin Microbiol 30:1752, 1992
35. Bagnarelli P, Menzo S, Manzin A, Giacca M, Varaldo PE, Clementi M: Detection of human immunodeficiency virus type-1 genomic RNA by reverse-transcription polymerase chain reaction. J Med Virol 34:89, 1995
36. Peri G, Milanese C, Matteucci C, Ruco L, Zhou D, Sozzani S, Coletta I, Mantovani A: A new monoclonal antibody (5D3-F7) which recognizes human monocyte-chemotactic protein-1 but not related chemokines. Development of a sandwich ELISA and in situ detection of producing cells. J Immunol Methods 174:249, 1994
37. Bernasconi S, Cinque P, Peri G, Sozzani S, Vicenzi E, Crociati A, Lazzarin A, Poli G, Mantovani A: Selective elevation of monocyte chemotactic protein-1 (MCP-1) in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis. J Infect Dis (in press)
38. Fernie BF, Poli G, Fauci AS: Alpha Interferon suppresses virion but not soluble human immunodeficiency virus antigen production in chronically infected T-lymphocytic cells. J Virol 65:968, 1991
39. Schuitemaker H, Koot M, Koostra NA, Dercksen MW, De Goede REY, Van Steenwijk RP, Lange JMA, Eeftink Schattenkerk JKM, Miedema F, Tersmette M: Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T cell-tropic virus populations. J Virol 66:1354, 1992
40. + T cells. Immunol Today 17:217, 1996
41. + lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234:1563, 1986
42. Huang Y, Zhang L, Ho DD: Biological characterization of nef in long-term survivors of human immunodeficiency virus type 1 infection. J Virol 69:8142, 1995
43. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, Saag MS, Shaw GM: Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117, 1995
44. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123, 1995
45. Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, Orenstein JM, Kotler DP, Fauci AS: HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362:355, 1993
46. Coffin JM: HIV population dynamics in vivo: Implication for genetic variation, pathogenesis, and therapy. Science 267:483, 1995
47. Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, Tenner-Racz K, Haase AT: Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362:359, 1993
48. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA: Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1157, 1996
49. Mantovani A, Sozzani S, Proost P, Van Damme J: The monocyte chemoattractant protein family, in Horuk R (ed): Chemoattractant Ligands and Their Receptors. Boca Raton, FL, CRC, 1996, pp 169-192
50. Baier M, Werner A, Bannert N, Metzner K, Kurth R: HIV suppression by interleukin-16. Nature 378:563, 1995
51. Paul W: Can the immune response control HIV infection? Cell 82:177, 1995